Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMT6H3J)

Drug Name

AbGn-168 Drug Info

Synonyms

AbGn-168H; Antibody 168 (autoimmune diseases), Boehringer Ingelheim/AbGenomics; Anti-CD162 mAb (psoriasis), Boehringer/AbGenomics

Indication

Disease Entry	ICD 11	Status	REF
Allergy	4A80-4A85	Phase 2	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting P-selectin glycoprotein ligand 1 (SELPLG)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Neihulizumab	DMUPZFO	Psoriatic arthritis	FA21	Phase 2	[3]
RO-4905417	DMV319J	Acute coronary syndrome	BA41	Phase 2	[4]
SelK2	DMM6B6E	Asthma	CA23	Phase 2	[5]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
P-selectin glycoprotein ligand 1 (SELPLG)	TTS5K8U	SELPL_HUMAN	Not Available	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01855880) Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Avarx.
3	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4	WO patent application no. 2013,0144,05, Methods.
5	Clinical pipeline report, company report or official report of Tetherex Pharmaceuticals